P-Pulmonale and New-Onset Atrial Fibrillation

被引：0

作者：

Aizawa, Yoshifusa ^{[1
]}

Sato, Masahito ^{[2
]}

机构：

[1] Tachikawa Med Ctr, Nagaoka, Niigata 9408621, Japan

[2] Tachikawa Gen Hosp, Nagaoka, Niigata, Japan

来源：

关键词：

RISK; DISEASE;

D O I：

10.1253/circj.CJ-13-1511

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：309 / 310

页数：2

共 15 条

[11] Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes
Nieuwlaat, Robby
Connolly, Stuart J.
[J]. HEART, 2009, 95 (02) : 95 - 97
[12] Psaty BM, 1997, CIRCULATION, V96, P2455
[13] ECHOCARDIOGRAPHIC PREDICTORS OF NONRHEUMATIC ATRIAL-FIBRILLATION - THE FRAMINGHAM-HEART-STUDY
VAZIRI, SM
LARSON, MG
BENJAMIN, EJ
LEVY, D
[J]. CIRCULATION, 1994, 89 (02) : 724 - 730
[14] Obesity and the risk of new-onset atrial fibrillation
Wang, TJ
Parise, H
Levy, D
Dagostino, RB
Wolf, PA
Vasan, RS
Benjamin, EJ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (20): : 2471 - 2477
[15] Metabolic syndrome and risk of development of atrial fibrillation - The Niigata Preventive Medicine Study
Watanabe, Hiroshi
Tanabe, Naohito
Watanabe, Toru
Darbar, Dawood
Roden, Dan M.
Sasaki, Shigeru
Aizawa, Yoshifusa
[J]. CIRCULATION, 2008, 117 (10) : 1255 - 1260